Rv2299c, a novel dendritic cell-activating antigen of
Rv2299c denatured by boiling for 30 min at 100°C or digested with proteinase K (PK, 10 μg/mL) for 1 hr at 37°C or DCs were pretreated with polymyxin B (50 μg/mL) for 1 hr prior to stimulation of the DCs. LPS (100 ng/ml) was used as control. After 24 hr, the quantities of TNF-α, IL-1β, and IL-6 in the culture medium were measured by ELISAs. All data are expressed as mean ± SD (n = 3) and statistical significance (*p < 0.05, **p < 0.01, or ***p < 0.001) is indicated for treatments compared to the controls, whereas treatments that showed no significant effect are indicated as n.s. DCs were stimulated with Rv2299c-ESAT-6 fusion protein denatured by boiling for 30 min at 100°C or digested with proteinase K (PK, 10 μg/mL) for 1 hr at 37°C or DCs were pretreated with polymyxin B (50 μg/mL) for 1 hr prior to stimulation of the DCs. LPS (100 ng/ml) was used as control. After 24 hr, the quantities of TNF-α, IL-1β, and IL-6 in the culture medium were measured by ELISAs. All data are expressed as mean ± SD (n = 3) and statistical significance (*p < 0.05, **p < 0.01, or ***p < 0.001) is indicated for treatments compared to the controls, whereas treatments that showed no significant effect are indicated as n.s.
